Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2009
10/15/2009WO2009126527A1 2h-benzo[b][1,4]oxazin-3(4h)-one derivatives for use as stearoyl coa desaturase inhibitors
10/15/2009WO2009126515A1 Compounds and compositions as protein kinase inhibitors
10/15/2009WO2009126514A1 Compounds and compositions as kinase inhibitors
10/15/2009WO2009126350A2 Methods and compositions for targeting polyubiquitin
10/15/2009WO2009126349A2 Methods and compositions related to internalizing rgd peptides
10/15/2009WO2009126335A2 Ant2 inhibitor compounds and methods of use thereof
10/15/2009WO2009126315A2 Macrocyclic compounds and methods of treatment
10/15/2009WO2009126274A2 Methods and compositions for the treatment of cancers, such as melanomas and gliomas
10/15/2009WO2009126153A1 Telomerase suppressor (lela1) compositions and methods for diagnosis and treatment of cancer in a mammalian subject
10/15/2009WO2009126123A1 Bicyclic nitrogen containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors
10/15/2009WO2009125861A1 Cysteine protease inhibitor
10/15/2009WO2009125858A1 Lipid dispersion preparation comprising 2-indolinone derivative
10/15/2009WO2009125798A1 Method for screening of pharmaceutical candidate substance for treatment of cancer in which hedgehog pathway is activated
10/15/2009WO2009125626A1 Mesothelioma-specific promoter and use thereof
10/15/2009WO2009125607A1 Apoptosis inducer
10/15/2009WO2009125597A1 Acylthiourea compound or salt thereof, and use of the compound or the salt
10/15/2009WO2009125230A1 Pharmaceutical compounds
10/15/2009WO2009125042A1 Glycosylated indolecarbazoles, method for obtaining same and uses thereof
10/15/2009WO2009125039A1 Antibodies for treating cancer
10/15/2009WO2009124968A1 Novel estrogen receptor ligands
10/15/2009WO2009124909A1 Use of xanthone derivatives as a medicament for cancer
10/15/2009WO2009124756A1 Use of aprepitant and derivatives thereof for the treatment of cancer
10/15/2009WO2009124636A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
10/15/2009WO2009124580A1 Modified hydroxypolymer conjugates with bone seeking and tumor killing moieties
10/15/2009WO2009124468A1 Anthracycline antibiotic derivatives with high activity, preparation methods and uses thereof
10/15/2009WO2009124460A1 Tripterygium wilfordii diterpene lactone derivatives, their pharmaceutical compositions and their application in inhibiting tumour of reproductive system
10/15/2009WO2009124399A1 Inhibition of cell migration by a farnesylated dibenzodiazepinone
10/15/2009WO2009124391A1 Anti-angiogenesis, anticancer proliferation properties of lymphocytic-derived microparticles
10/15/2009WO2009124381A1 An anti-cancer cytotoxic monoclonal antibody
10/15/2009WO2009103969A4 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions
10/15/2009WO2009102367A3 Tight junction protein modulators and uses thereof
10/15/2009WO2009102240A3 Medicinal agent for treating oncological diseases
10/15/2009WO2009101263A3 Soluble complexes of curcumin
10/15/2009WO2009098715A3 Novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents
10/15/2009WO2009095712A3 4-(3-amin0pyraz0le) pyrimidine derivatives for use as jak kinase inhibitors in the treatment of cancer
10/15/2009WO2009089366A3 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulators
10/15/2009WO2009078931A9 Irf as a tumor suppressor and uses thereof
10/15/2009WO2009077755A3 Latency associated protein construct with aggrecanase sensitive cleavage site
10/15/2009WO2009073148A3 Polymorphs of n-malonyl-bis(n'-methyl-n'-thiobenzoylhydrazide)
10/15/2009WO2009072062A3 Derivatives of dihydroxypyrrolidine as anti- cancer compounds
10/15/2009WO2009066072A3 Inhibitors of 17beta-hydroxysteroid dehydrogenase
10/15/2009WO2009053445A3 Polymorphic forms of ibandronate sodium and processes for preparation thereof
10/15/2009WO2009047794A3 Docetaxel injectable composition, being absolutely free of ethanol
10/15/2009WO2009043465A3 Use of beta-endorphin as a therapeutic agent
10/15/2009WO2009033780A3 Use of growth hormone-releasing factor and/or k237 as a therapeutic agents
10/15/2009WO2009033768A3 Use of a peptide as a therapeutic agent
10/15/2009WO2009016460A8 Pyrazole compounds and their use as raf inhibitors
10/15/2009WO2009015000A8 Pyrazole urea derivatives used as kinase inhibitors
10/15/2009WO2008122039A3 Selenocysteine mediated hybrid antibody molecules
10/15/2009US20090259167 Methods and compositions for dose-dependent photodynamic therapy of disorders
10/15/2009US20090259022 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/15/2009US20090258944 Method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewith, and their use
10/15/2009US20090258942 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
10/15/2009US20090258937 Methods for Modulating Tumor Growth and Metastasis
10/15/2009US20090258936 Cxcr2 inhibitors
10/15/2009US20090258930 Double stranded rna structures and constructs, and methods for generating and using the same
10/15/2009US20090258929 Compositions and Methods for Modulating mTOR Signaling
10/15/2009US20090258918 EP4 receptor agonist, compositions and methods thereof
10/15/2009US20090258914 Inhibitor of Anti-Apoptotic Proteins
10/15/2009US20090258910 benzo[1,3]dioxol-5-yl-carbamic acid 6-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)-naphthalen-2-yl ester and benzo[1,3]dioxol-5-yl-carbamic acid 8-(2-phenyl-5-pyridin-4-yl-1H-imidazol-4-yl)-naphthalen-2-yl ester;
10/15/2009US20090258909 Novel Benzimidazole Derivatives Useful as Selective Androgen Receptor Modulators (SARMS)
10/15/2009US20090258906 Cxcr2 antagonists
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
10/15/2009US20090258890 Topoisomerase-targeting agents
10/15/2009US20090258888 Pyrimidine Derivatives
10/15/2009US20090258886 Heteroalkyl linked pyrimidine derivatives
10/15/2009US20090258882 2,4-Substituted Quinazolines as Lipid Kinase Inhibitors
10/15/2009US20090258878 Triazine derivative compound and composition for treating cancer containing them
10/15/2009US20090258873 Novel tetrahydropyridothiophenes
10/15/2009US20090258870 Novel ansamitocin derivatives
10/15/2009US20090258861 Tetrahydronaphthyridine Derivatives
10/15/2009US20090258857 Chemical compounds
10/15/2009US20090258855 Bicyclic triazoles as protein kinase modulators
10/15/2009US20090258819 Reagents and Methods for Smooth Muscle Therapies
10/15/2009US20090258426 Preferred segments of neural thread protein and method of using the same
10/15/2009US20090258409 Purified sr-p70 protein
10/15/2009US20090258096 Anticancer Methods Employing Extracts of Gleditsia sinensis Lam
10/15/2009US20090258089 Chemo- and Radiation-sensitization of Cancer by Antisense TRPM-2 Oligodeoxynucleotides
10/15/2009US20090258071 Compositions and methods for ph targeted drug delivery
10/15/2009US20090258064 Compositions of ucp inhibitors, fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor
10/15/2009US20090258046 Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
10/15/2009US20090258032 Methods and compositions targeting viral and cellular itam motifs, and use of same in identifying compounds with therapeutic activity
10/15/2009US20090258021 Genes associated with mechanical stress, expression products therefrom, and uses thereof
10/15/2009US20090258020 Antibody designated barb3, barb3 related antibodies, and methods of making and using same
10/15/2009US20090258019 Diagnosis of carcinoma using RAIG1 polypeptides
10/15/2009US20090258016 Substituted imidazole derivatives
10/15/2009US20090258014 Combination of hgf inhibitor and egf inhibitor to treat cancer
10/15/2009US20090258013 Novel compositions and methods for the treatment of immune related diseases
10/15/2009US20090258007 Anti-Perp Antibody
10/15/2009US20090257994 Chimeric immunoreceptor useful in treating human cancers
10/15/2009US20090257991 Engineering and Delivery of Therapeutic Compositions of Freshly Isolated Cells
10/15/2009US20090257977 Novel tetrahydropyridothiophenes
10/15/2009DE102008017853A1 Thienopyrimidine Thienopyrimidines
10/15/2009DE102008015607A1 New boswellic acid derivatives are microsomal prostaglandin E-1 synthesis inhibitors, useful to treat e.g. rheumatoid arthritis, inflammatory bowel disease, asthma, feverish and painful conditions, cancers, emphysema and multiple sclerosis
10/15/2009CA2725390A1 Use of a hdac inhibitor and a her-2 inhibitor in the treatment of breast cancer
10/15/2009CA2721346A1 Bis-aromatic anticancer agents
10/15/2009CA2721163A1 Macrocyclic compounds and methods of treatment
10/15/2009CA2721140A1 Tetracyclic anthraquinone antibiotic derivatives with high activity, process for preparing the same and use thereof
10/15/2009CA2721080A1 Estrogenic extracts of anemarrhena asphodeloides bge. from the liliaceae family and uses thereof
10/15/2009CA2721072A1 Anticancer methods employing extracts of gleditsia sinensis lam
1 ... 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 ... 2211